Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) is an effective therapeutic option for Parkinson’s disease (PD) patients whose symptoms are not ...
Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an established treatment for dystonia, yet the neurophysiological mechanisms underlying frequency-dependent effects remain poorly ...
Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care. Living with Parkinson disease presents daily challenges that may ...
The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...
Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...
Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...